Survival and Complications of Beta-Thalassemia in Lebanon

被引:23
|
作者
Charafeddine, K.
Isma'eel, H.
Charafeddine, M.
Inati, A. [2 ,3 ]
Koussa, S. [3 ]
Naja, M.
Taher, A. [1 ,3 ]
机构
[1] Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon
[2] Rafik Hariri Univ Hosp, Beirut, Lebanon
[3] Chron Care Ctr, Hazmieh, Lebanon
关键词
beta-Thalassemia; Lebanon; Complications; Survival;
D O I
10.1159/000171088
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
beta-Thalassemia major is a debilitating disease with a considerable incidence in Lebanon (around 2-3% carriership). The present article describes our experience to this day with 214 patients, emphasizing the survival of beta-thalassemia major and development of complications among patients with different parameters. Fifteen deaths were reported. The most common cause of death was heart failure (60%). Patients with a ferritin level of 3,000 ng/ml showed better survival than those with a level 1 3,000 ng/ml (p < 0.006). In addition, patients with a ferritin level of 1,500 ng/ml showed less complication-free survival than those with a level 1 1,500 ng/ml (p < 0.024). High level of ferritin (1,500 ng/ml) is associated with increased risk of heart failure. Overall and complication-free survival were statistically different among patients classified according to birth cohort or ferritin level. The Chronic Care Center, a multidisciplinary center located in the suburbs of Beirut, led to an increase in complication-free as well as overall survival. Although patients are being diagnosed earlier and chelation therapy is being initiated at an earlier age, complications due to iron overload still persist. The introduction of new oral iron chelators and better iron overload quantitation methods will most likely modify this picture, and a follow-up study will examine their impact. Copyright (C) 2008 S. Karger AG, Basel
引用
收藏
页码:112 / 116
页数:5
相关论文
共 50 条
  • [31] Globin mRNA in beta-thalassemia heterozygotes with different beta-thalassemia alleles and in heterozygotes for hereditary persistence of fetal hemoglobin
    Smetanina, NS
    Adekile, AD
    Huisman, THJ
    ACTA HAEMATOLOGICA, 1996, 96 (03) : 162 - 169
  • [32] Survival and complications in thalassemia
    Borgna-Pignatti, C
    Cappellini, MD
    De Stefano, P
    Del Vecchio, GC
    Forni, GL
    Gamberini, MR
    Ghilardi, R
    Origa, R
    Piga, A
    Romeo, MA
    Zhao, H
    Cnaan, A
    COOLEY'S ANEMIA EIGHTH SYMPOSIUM, 2005, 1054 : 40 - 47
  • [33] Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia
    Karimi, Mehran
    Borzouee, Mohammad
    Mehrabani, Alireza
    Cohan, Nader
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (03) : 213 - 218
  • [34] Study of Beta-Thalassemia Biomarkers and Their Relationship to Cognition Among Children
    Shehata, Ghaydaa A.
    Elsayh, Khaled I.
    Rafet, Nafisa H.
    Mohamed, Amany O.
    Rageh, Tarek A.
    JOURNAL OF CHILD NEUROLOGY, 2010, 25 (12) : 1473 - 1479
  • [35] Treatment strategies for hemoglobin E beta-thalassemia
    Olivieri, Nancy F.
    BLOOD REVIEWS, 2012, 26 : S28 - S30
  • [36] Subclinical autonomic dysfunction in patients with beta-thalassemia
    Elefterios Stamboulis
    Nikoleta Vlachou
    Konstantinos Voumvourakis
    Athina Andrikopoulou
    Chrisa Arvaniti
    Athanasios Tsivgoulis
    Dimitrios Athanasiadis
    Sotirios Tsiodras
    Nikolaos Tentolouris
    Heleni Triantafyllidi
    Marouso Drossou-Servou
    Aphrodite Loutradi-Anagnostou
    Georgios Tsivgoulis
    Clinical Autonomic Research, 2012, 22 : 147 - 150
  • [37] FOUNDER EFFECT IN BETA-THALASSEMIA IN PORTNEUF, QUEBEC
    DEBRAEKELEER, M
    DAO, TN
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1993, 35 (04): : 447 - 450
  • [38] Neurophysiologic and intellectual evaluation of beta-thalassemia patients
    Economou, M
    Zafeiriou, DI
    Kontopoulos, E
    Gompakis, N
    Koussi, A
    Perifanis, V
    Athanassiou-Metaxa, M
    BRAIN & DEVELOPMENT, 2006, 28 (01) : 14 - 18
  • [39] Hypercoagulability in Sickle Cell Disease and Beta-Thalassemia
    Singer, Sylvia T.
    Ataga, Kenneth I.
    CURRENT MOLECULAR MEDICINE, 2008, 8 (07) : 639 - 645
  • [40] Effect of beta-Thalassemia on Some Biochemical Parameters
    Rasheed, Nazdar Ezzaddin
    Ahmed, Salar Adnan
    WORLD FAMILY MEDICINE, 2009, 7 (02): : 21 - 24